13F HOLDINGS REPORT
Qiming U.S. Ventures Management, LLC
Quarter ended Q1 2025 · Filed May 15, 2025 · Accession 0001415889-25-013135
Total Value
$23.1M
Positions
6
Other Managers
0
Confidential Omitted
No
Holdings (6)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | TOURMALINE BIO INC | 89157D105 | 741,691 | $11.3M | 48.83% |
| 2 | KORRO BIO INC | KRRO | 368,085 | $6.4M | 27.74% |
| 3 | JASPER THERAPEUTICS INC | JSPRW | 928,964 | $4.0M | 17.29% |
| 4 | HILLEVAX INC | 43157M102 | 372,615 | $540,292 | 2.34% |
| 5 | VENTYX BIOSCIENCES INC | 92332V107 | 412,225 | $474,059 | 2.05% |
| 6 | KEZAR LIFE SCIENCES INC | KZR | 82,871 | $404,410 | 1.75% |